Quarterly report pursuant to Section 13 or 15(d)

Note 19 - Segment Information: Schedule of Segment Information (Details)

v3.21.1
Note 19 - Segment Information: Schedule of Segment Information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating income (loss) $ (164,743) $ (236,723)
Interest income 16,489 19,403
Interest expense 12,070 7,337
Cannabis and Medical Marijuana Segment    
Net revenue 10,871 12,538
Operating income (loss) 6,125 (8,905)
Interest income 0 24
Interest expense 0 0
Property additions 0 0
Depreciation and amortization 0 0
Total assets 1,005,990 2,343,236
Facility Operations Related    
Net revenue 1,309,753 1,136,924
Operating income (loss) (3,946) 34,176
Interest income 0 0
Interest expense 8,498 8,471
Property additions 6,595 3,329
Depreciation and amortization 7,960 2,640
Total assets 2,124,769 1,657,984
Corporate and Eliminations    
Net revenue 0 0
Operating income (loss) (166,922) (261,994)
Interest income 16,489 19,379
Interest expense 3,572 (1,134)
Property additions 1,264 0
Depreciation and amortization 1,461 1,202
Total assets 1,644,546 764,633
Consolidated    
Net revenue 1,320,624 1,149,462
Operating income (loss) (164,743) (236,723)
Interest income 16,489 19,403
Interest expense 12,070 7,337
Property additions 7,859 3,329
Depreciation and amortization 9,421 3,842
Total assets $ 4,775,305 $ 4,765,853